Di Sario et al., have also shown that Cariporide, through its selective inhibition of NHE1 and subsequent decrease of intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells [296], leading these authors to suggest the potential therapeutic value of Cariporide against this human tumor. This evidence concerns the gene SLC9A1 and neoplasm.